Clinical Trial: Management of Dysuria and Irritative Symptoms After HoLEP: A Prospective Study Evaluating the Efficacy of Alpha-Blocker Therapy

U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06865430) titled 'Management of Dysuria and Irritative Symptoms After HoLEP: A Prospective Study Evaluating the Efficacy of Alpha-Blocker Therapy' on March 04.

Brief Summary: Holmium Laser Enucleation of the Prostate (HoLEP) is an increasingly popular endoscopic minimally invasive surgical technique for the treatment of benign prostatic hyperplasia (BPH). In the literature, the long-term efficacy and low complication rates of HoLEP have been highlighted in many studies. However, in the early postoperative period, particularly within the first three months, irritative symptoms are reported in 17-35% of cases (1-2).

The pathophysiology of postoperativ...